Triflo Arocap is a once-daily inhalation capsule designed for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) and asthma in adults aged 18 years and older. This dry powder inhalation capsule combines three active ingredients:
Fluticasone Furoate (100 mcg): An inhaled corticosteroid (ICS) that reduces inflammation in the airways.
Umeclidinium Bromide (62.5 mcg): A long-acting muscarinic antagonist (LAMA) that helps relax airway muscles.
Vilanterol Trifenatate (25 mcg): A long-acting beta2-adrenergic agonist (LABA) that aids in bronchodilation.
Together, these components work synergistically to improve lung function, reduce symptoms, and decrease the frequency of exacerbations in COPD and asthma patients.